A
A

AssicurazioniGenerali

交易方向

交易者脈動

技術摘要

小時

財經新聞

JPM stays upbeat on European insurance into 2024

BUZZ-JPM stays upbeat on European insurance into 2024 ** J.P.Morgan remains positive on European insurance in 2024, citing peak yields, no threat from peak pricing, earnings growth, and benign credit risk ** The broker says peak yields are likely to be a net positive, especially for high capital return stocks such as UK life and Benelux names, addi
A
A
A
A
B
H
J
L
L
P
S
S
A
P
S
Z

Generali's Sosteneo, Edison, Saipem to decarbonise Taranto steel plant

Generali's Sosteneo, Edison, Saipem to decarbonise Taranto steel plant MILAN, Nov 30 (Reuters) - Generali's GASI.MI green transition investment manager Sosteneo SGR said on Thursday it had teamed up with Edison EDNn.MI and Saipem SPMI.MI to develop a project to decarbonise Italy's largest energy and steel hub. The project is part of a wider initiative dubbed Puglia Green Hydrogen Valley, which involves a bespoke decarbonisation solution consisting of 260 megawatts (MW) of solar photovoltaic (PV)
S
A

Italy - Factors to watch on Nov. 30

Italy - Factors to watch on Nov. 30 The following factors could affect Italian markets on Thursday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy. New items are marked with (*). For a complete list of diary events in Italy please click on IT/DIA . ECONOMY ISTAT releases October unemployment rate data (0900 GMT) and November CPI flash data (1000 GMT).
E
E
E
F
L
R
S
U
A
F
I
I
U

BNP Paribas Cardif buys 51% of ICCREA's insurance arm

BNP Paribas Cardif buys 51% of ICCREA's insurance arm MILAN, Nov 27 (Reuters) - BNP Paribas Cardif has bought a majority stake in the insurance arm of Italy's BCC ICCREA under an agreement that will enable it to sell life insurance through the cooperative group's banks for 15 years, the two companies said on Monday. Under the deal, the unit of French bank BNP Paribas BNPP.PA will buy 51% of BCC Vita, ICCREA's insurance arm, with the option to acquire a further 19%.
B
A
I

AstraZeneca, Barclays, BASF SE

EUROPE RESEARCH ROUNDUP-AstraZeneca, Barclays, BASF SE Nov 27 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including AstraZeneca, Barclays, and BASF SE on Monday. HIGHLIGHTS * AstraZeneca AZN.L : Jefferies cuts target price to 12500p from 13000p * Barclays BARC.L : Jefferies cuts target price to 230p from 300p * BASF SE BASFn.DE : Morgan Stanley cuts to underweight from equalweight * Elior ELIOR.PA : Deutsche Bank raises to buy from hold
A
A
A
A
A
A
B
B
B
B
B
B
B
B
C
D
D
E
E
E
F
G
H
I
A
H
A
D
I

細節

熱門資產

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

我們運用 cookies 提供您最佳之網頁使用經驗。更改您的cookie 設定跟詳情。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明